279 related articles for article (PubMed ID: 27908534)
21. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
22. Dermatomyositis and polymyositis: new treatment targets on the horizon.
Hak AE; de Paepe B; de Bleecker JL; Tak PP; de Visser M
Neth J Med; 2011 Oct; 69(10):410-21. PubMed ID: 22058260
[TBL] [Abstract][Full Text] [Related]
23. Intravenous Immunoglobulin for Inflammatory Myositis: Experience in a Tertiary Medical Center.
Ohad M; Shemer A; Lavie I; Ozeri D; Shoenfeld Y; Kivity S
J Clin Rheumatol; 2021 Dec; 27(8):e616-e621. PubMed ID: 32501943
[TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
[TBL] [Abstract][Full Text] [Related]
25. Profile of Pediatric Idiopathic Inflammatory Myopathies from a Tertiary Care Center of Eastern India.
Sarkar S; Mondal T; Saha A; Mondal R; Datta S
Indian J Pediatr; 2017 Apr; 84(4):299-306. PubMed ID: 28251541
[TBL] [Abstract][Full Text] [Related]
26. A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases.
Danieli MG; Tonacci A; Paladini A; Longhi E; Moroncini G; Allegra A; Sansone F; Gangemi S
Autoimmun Rev; 2022 Jun; 21(6):103105. PubMed ID: 35452850
[TBL] [Abstract][Full Text] [Related]
27. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
28. Subcutaneous IgG in the Myositis Spectrum Disorders.
Danieli MG; Gelardi C; Pedini V; Logullo F; Gabrielli A
Curr Rheumatol Rev; 2018; 14(3):194-199. PubMed ID: 28292255
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
Pongratz D
J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
Ernste FC; Reed AM
Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
[TBL] [Abstract][Full Text] [Related]
31. Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial.
Kamperman RG; Bogaards JA; Evers SW; Walter HAW; de Visser M; de Borgie C; Colen-de Koning JCA; Verhamme C; Maas M; Eftimov F; van Schaik IN; van der Kooi AJ; Raaphorst J
BMJ Open; 2023 Jul; 13(7):e067435. PubMed ID: 37429682
[TBL] [Abstract][Full Text] [Related]
32. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
Chérin P; Herson S
Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
[TBL] [Abstract][Full Text] [Related]
33. Biologic therapy in the idiopathic inflammatory myopathies.
Khoo T; Limaye V
Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207
[TBL] [Abstract][Full Text] [Related]
34. Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases.
Cherin P; Belizna C; Cartry O; Lascu-Dubos G; de Jaeger C; Delain JC; Crave JC; Hachulla E
Autoimmun Rev; 2016 Mar; 15(3):281-6. PubMed ID: 26688441
[TBL] [Abstract][Full Text] [Related]
35. Update on the pharmacological treatment of adult myositis.
Oddis CV
J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
[TBL] [Abstract][Full Text] [Related]
36. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
37. Recent clinical trials in idiopathic inflammatory myopathies.
Leclair V; Lundberg IE
Curr Opin Rheumatol; 2017 Nov; 29(6):652-659. PubMed ID: 28763333
[TBL] [Abstract][Full Text] [Related]
38. Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study.
Ziade N; Aoude M; Hmamouchi I; R N; Lilleker JB; Sen P; Joshi M; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Knitza J; Kuwana M; Nune A; Cavagna L; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 Mar; 63(3):657-664. PubMed ID: 37228012
[TBL] [Abstract][Full Text] [Related]
39. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials.
Dalakas MC
Neurol Sci; 2003 Oct; 24 Suppl 4():S256-9. PubMed ID: 14598055
[TBL] [Abstract][Full Text] [Related]
40. Treatment of inflammatory myopathy with intravenous gamma globulin.
Sussman GL; Pruzanski W
Curr Opin Rheumatol; 1995 Nov; 7(6):510-5. PubMed ID: 8579971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
